March 2015 Issue of The Ophthalmologist

This time around, The Ophthalmologist Power List seeks ophthalmology’s rising stars.

Which anti-VEGF agent works best in patients with DME? The US government sponsored the DRCR.net’s Protocol T trial to find out.

Italy reimburses off-label bevacizumab use in ophthalmology – pharma complains to the European Commission.

The prevalence of myopia in Chinese children in middle-income areas far outstrips that of low-income areas – even after accounting for all known risk factors.

Scleral contact lens plus smart spectacles equals 2.8 × magnification with a wink.

After a stroke, the brain swells... and for every millimeter that the optic nerve sheath diameter swells, the risk of death increases by 4–6 times.

One Tumblr post “broke the internet” and was a massive distraction during the 38th Annual Macula Society meeting – but what’s really going on in the visual pathway?

Damage to the primary visual cortex strengthens neuronal connectivity between the retina and pulvinar nucleus of the thalamus – and might explain a few phenomena.

Four people, three stories, one topic: entrepreneurship

How they decided to build a new ophthalmology institute, ELZA

Building a highly successful cataract and refractive practice in Ireland

Making the leap from the NHS to starting an eye hospital, and designing, developing and marketing a new IOL design

Corneal cross-linking can halt the progression of keratoconus, but what is the best approach to treatment?

What does analysis of the last five years of the AMD literature tell us about the priorities of the field and the major contributors to it?

We ask the next generation of ophthalmology researchers why they do what they do – and where they want to be 10 years from now.

Windows XP is dead. No support, no security patches, nothing. You might have PCs or instruments in your office that still need XP to function – so what are the risks that you run?

Sitting Down With… V.K. Raju, Founder and Medical Director of the Eye Foundation of America (EFA), a charitable organization that provides eye care to children in 21 developing countries

With many causes, great prevalence, and substantial underdiagnosis, dry eye disease poses a great burden on patients and your practice

Dry Eye Disease’s Big Diagnostic Challenge

Five Things We Learned This Month: